Zacks Investment Research Upgrades Dextera Surgical (DXTR) to Hold

Zacks Investment Research upgraded shares of Dextera Surgical (NASDAQ:DXTR) from a sell rating to a hold rating in a research note published on Tuesday morning.

According to Zacks, “Dextera Surgical Inc. designs and manufactures proprietary stapling devices for surgical procedures. The company’s product consists of MicroCutter 5/80 use for transection and resection in urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the intestine and the transection of the appendix. Dextera Surgical Inc., formerly known as Cardica Inc., is headquartered in Redwood City, California. “

Separately, Ladenburg Thalmann Financial Services initiated coverage on Dextera Surgical in a research report on Wednesday, August 16th. They issued a buy rating and a $0.80 price objective for the company.

Shares of Dextera Surgical (DXTR) traded down $0.01 during mid-day trading on Tuesday, reaching $0.05. The company had a trading volume of 3,903,161 shares, compared to its average volume of 3,050,000. Dextera Surgical has a 1 year low of $0.04 and a 1 year high of $2.33.

Dextera Surgical (NASDAQ:DXTR) last announced its quarterly earnings data on Thursday, November 9th. The medical instruments supplier reported ($0.09) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.02). The company had revenue of $0.69 million during the quarter, compared to analysts’ expectations of $0.62 million. analysts anticipate that Dextera Surgical will post -0.27 EPS for the current year.

A hedge fund recently raised its stake in Dextera Surgical stock. Virtu KCG Holdings LLC raised its stake in shares of Dextera Surgical Inc (NASDAQ:DXTR) by 1,380.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 369,918 shares of the medical instruments supplier’s stock after buying an additional 344,933 shares during the quarter. Virtu KCG Holdings LLC owned about 4.14% of Dextera Surgical worth $111,000 at the end of the most recent reporting period. 4.49% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Zacks Investment Research Upgrades Dextera Surgical (DXTR) to Hold” was originally published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.thelincolnianonline.com/2017/12/16/zacks-investment-research-upgrades-dextera-surgical-dxtr-to-hold.html.

About Dextera Surgical

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Get a free copy of the Zacks research report on Dextera Surgical (DXTR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Dextera Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply